Goldman Sachs Group Inc X Biotech Inc. Transaction History
Goldman Sachs Group Inc
- $613 Billion
- Q4 2024
A detailed history of Goldman Sachs Group Inc transactions in X Biotech Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 53,730 shares of XBIT stock, worth $179,458. This represents 0.0% of its overall portfolio holdings.
Number of Shares
53,730
Previous 40,418
32.94%
Holding current value
$179,458
Previous $312,000
32.05%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding XBIT
# of Institutions
52Shares Held
4.9MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY1.13MShares$3.79 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.06MShares$3.56 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA452KShares$1.51 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny281KShares$938,6030.0% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL254KShares$847,5910.0% of portfolio
About XBiotech Inc.
- Ticker XBIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,439,300
- Market Cap $102M
- Description
- XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...